NXTC
NextCure Inc
NASDAQ: NXTC · HEALTHCARE · BIOTECHNOLOGY
$9.21
+3.02% today
Updated 2026-04-30
Market cap
$34.70M
P/E ratio
—
P/S ratio
9.52x
EPS (TTM)
$-19.65
Dividend yield
—
52W range
$4 – $16
Volume
0.1M
WallStSmart proprietary scores
24
out of 100
Grade: F
Strong Sell
Investment rating
3.7
Growth
D5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$17.67
+91.86%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-7.64M
- Revenue declining -100.00% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-69.43M | $-62.72M | $-55.65M | $-55.84M | $-9.44M |
| EPS | — | — | — | — | $-19.65 |
| Free cash flow | $-56.00M | $-53.79M | $-41.28M | $-49.61M | $-7.64M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
NextCure Inc trades at $9.21. Our Smart Value Score of 24/100 indicates the stock is weak.
Frequently asked questions
What is NextCure Inc's stock price?
NextCure Inc (NXTC) trades at $9.21.
Is NextCure Inc overvalued?
Smart Value Score 24/100 (Grade F, Strong Sell).
What is the price target of NextCure Inc (NXTC)?
The analyst target price is $17.67, representing +91.9% upside from the current price of $9.21.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio9.52x
ROE-111.20%
Beta1.58
50D MA$11.81
200D MA$9.55
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—